2017
DOI: 10.6061/clinics/2017(04)08
|View full text |Cite
|
Sign up to set email alerts
|

Human islet xenotransplantation in rodents: A literature review of experimental model trends

Abstract: Among the innovations for the treatment of type 1 diabetes, islet transplantation is a less invasive method of treatment, although it is still in development. One of the greatest barriers to this technique is the low number of pancreas donors and the low number of pancreases that are available for transplantation. Rodent models have been chosen in most studies of islet rejection and type 1 diabetes prevention to evaluate the quality and function of isolated human islets and to identify alternative solutions to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 48 publications
0
4
0
Order By: Relevance
“…Similar islet numbers (2,000-3,000) are reported by others for s.c. normoglycemia in xenograft models in immune-compromised mice (13,30,32). The success (or lack of success) of xenogeneic islet transplantation, largely in the kidney capsule, has been reviewed elsewhere (33). With modules containing HUVEC, 750 IEQ was sufficient to restore normoglycemia in this immune-compromised xenograft model.…”
Section: Discussionmentioning
confidence: 95%
“…Similar islet numbers (2,000-3,000) are reported by others for s.c. normoglycemia in xenograft models in immune-compromised mice (13,30,32). The success (or lack of success) of xenogeneic islet transplantation, largely in the kidney capsule, has been reviewed elsewhere (33). With modules containing HUVEC, 750 IEQ was sufficient to restore normoglycemia in this immune-compromised xenograft model.…”
Section: Discussionmentioning
confidence: 95%
“…Currently, islet transplantation is the main way to cure diabetes completely. However, the lack of available donor islets has prevented extensive use of this method [ 44 ]. Thus, identification of alternative islet sources may provide a gateway to widespread use of this practice to treat diabetes.…”
Section: Discussionmentioning
confidence: 99%
“…The liver is still considered the most appropriate location of the implant in clinical practise, however immunological, anatomical and physiological factors have contributed to a need for locations with better results [ 5 ]. Currently the most common experimental site is the renal capsule, which is the subject of 70% of published research [ 6 , 13 ].…”
Section: Introductionmentioning
confidence: 99%